Zheng Ting, Huang Kai-Yue, Tang Xu-Dong, Wang Feng-Yun, Lv Lin
Graduate School, China Academy of Chinese Medical Sciences, Beijing 100091, China.
Institute of Digestive Diseases, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing 100091, China.
World J Gastroenterol. 2025 Apr 7;31(13):104671. doi: 10.3748/wjg.v31.i13.104671.
Eukaryotic cells contain the endoplasmic reticulum (ER), a prevalent and intricate membranous structural system. During the development of inflammatory bowel disease (IBD), the stress on the ER and the start of the unfolded protein response are very important. Some chemicals, including 4μ8C, small molecule agonists of X-box binding protein 1, and ISRIB, work on the inositol-requiring enzyme 1, turn on transcription factor 6, and activate protein kinase RNA-like ER kinase pathways. This may help ease the symptoms of IBD. Researchers investigating the gut microbiota have discovered a correlation between ER stress and it. This suggests that changing the gut microbiota could help make new medicines for IBD. This study looks at how ER stress works and how it contributes to the emergence of IBD. It also talks about its possible clinical importance as a therapeutic target and looks into new ways to treat this condition.
真核细胞含有内质网(ER),这是一种普遍且复杂的膜性结构系统。在炎症性肠病(IBD)的发展过程中,内质网应激和未折叠蛋白反应的启动非常重要。一些化学物质,包括4μ8C、X盒结合蛋白1的小分子激动剂和ISRIB,作用于肌醇需求酶1,开启转录因子6,并激活蛋白激酶RNA样内质网激酶途径。这可能有助于缓解IBD的症状。研究肠道微生物群的研究人员发现了内质网应激与肠道微生物群之间的关联。这表明改变肠道微生物群可能有助于开发治疗IBD的新药。这项研究探讨了内质网应激的作用机制及其如何导致IBD的出现。它还讨论了内质网应激作为治疗靶点的潜在临床重要性,并研究了治疗这种疾病的新方法。